ES2229515T3
(es)
|
1997-07-01 |
2005-04-16 |
Warner-Lambert Company Llc |
Derivados 4-bromo o 4-yodo del acido fenilamino benzhidroxamico y su uso como inhibidores de la mek.
|
US5932580A
(en)
|
1997-12-01 |
1999-08-03 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
PDGF receptor kinase inhibitory compounds their preparation and compositions
|
MXPA00010150A
(es)
|
1998-04-17 |
2002-05-14 |
Parker Hughes Inst |
Inhibidores de btk y metodos para su identificacion y uso.
|
BR9911017A
(pt)
|
1998-05-04 |
2001-02-06 |
Asta Medica Ag |
Derivados de indol e seu emprego para o tratamento de doenças malignas e outras, que se baseiam na proliferação de células patológicas
|
CA2349832A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as mek inhibitors
|
CA2348236A1
(en)
|
1999-01-13 |
2000-07-20 |
Stephen Douglas Barrett |
4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
|
HUP0105113A3
(en)
|
1999-01-13 |
2004-11-29 |
Warner Lambert Co |
Benzoheterocycles and their use as mek inhibitors and pharmaceutical compositions containing the compounds
|
AU2482800A
(en)
|
1999-01-13 |
2000-08-01 |
Warner-Lambert Company |
Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
|
WO2000056706A1
(en)
|
1999-03-19 |
2000-09-28 |
Du Pont Pharmaceuticals Company |
Amino-thio-acrylonitriles as mek inhibitors
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
US8137695B2
(en)
|
2006-08-18 |
2012-03-20 |
Arrowhead Madison Inc. |
Polyconjugates for in vivo delivery of polynucleotides
|
US6797706B1
(en)
|
1999-06-09 |
2004-09-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Heterocyclecarboxamide derivative
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
ATE277044T1
(de)
|
1999-10-06 |
2004-10-15 |
Boehringer Ingelheim Pharma |
Heterocyclische verbindungen verwendbar als tyrosinkinase inhibitoren
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
IL150388A0
(en)
|
1999-12-24 |
2002-12-01 |
Aventis Pharma Ltd |
Azaindoles
|
EP1250137B1
(en)
|
2000-01-24 |
2007-08-15 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis
|
SK287142B6
(sk)
|
2000-02-15 |
2010-01-07 |
Sugen, Inc. |
Inhibítory proteínkináz na báze pyrolom substituovaného 2-indolinónu, farmaceutický prípravok s ich obsahom a ich použitie
|
US7087608B2
(en)
|
2000-03-03 |
2006-08-08 |
Robert Charles Atkins |
Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
|
AU2001247372A1
(en)
|
2000-03-15 |
2001-09-24 |
Warner Lambert Company |
5-amide substituted diarylamines as mex inhibitors
|
AR035851A1
(es)
|
2000-03-28 |
2004-07-21 |
Wyeth Corp |
3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
DE10017480A1
(de)
|
2000-04-07 |
2001-10-11 |
Transmit Technologietransfer |
Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren
|
JP2001302667A
(ja)
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
WO2002069960A2
(en)
|
2001-03-06 |
2002-09-12 |
Axxima Pharmaceuticals Ag |
Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock
|
DE60231868D1
(de)
|
2001-04-24 |
2009-05-20 |
Purdue Research Foundation |
Folat-mimetika und deren folatrezeptorbindende konjugate
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
WO2003004006A2
(en)
|
2001-06-29 |
2003-01-16 |
Ab Science |
Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
|
CA2452171A1
(en)
|
2001-06-29 |
2003-01-09 |
Ab Science |
Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
|
JP2005500041A
(ja)
|
2001-06-29 |
2005-01-06 |
アブ サイエンス |
強力で選択的かつ非毒性のc−kit阻害剤
|
CA2461181A1
(en)
|
2001-09-20 |
2003-05-01 |
Ab Science |
Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
|
JP2005508337A
(ja)
|
2001-09-27 |
2005-03-31 |
スミスクライン ビーチャム コーポレーション |
化合物
|
US20030158195A1
(en)
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
UA76837C2
(uk)
|
2002-03-13 |
2006-09-15 |
Еррей Байофарма Інк. |
N3 алкіловані похідні бензімідазолу як інгібітори мек
|
US7235537B2
(en)
|
2002-03-13 |
2007-06-26 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
ES2549159T3
(es)
|
2002-03-13 |
2015-10-23 |
Array Biopharma, Inc. |
Derivados de bencimidazol N3-alquilados como inhibidores de MEK
|
AU2003233946A1
(en)
|
2002-03-15 |
2003-09-29 |
Novartis Ag |
4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
|
MXPA04011048A
(es)
|
2002-05-06 |
2005-02-17 |
Vertex Pharmaceutivals Inc |
Tiadiazol o oxasiazoles y su uso como inhibidores de proteina cinasa jak.
|
AU2003231880A1
(en)
|
2002-05-30 |
2003-12-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of jak and cdk2 protein kinases
|
GB0215823D0
(en)
|
2002-07-09 |
2002-08-14 |
Astrazeneca Ab |
Quinazoline derivatives
|
JP4511352B2
(ja)
|
2002-07-25 |
2010-07-28 |
ファイザー・インク |
抗癌薬として有用なイソチアゾール誘導体
|
DK1525200T3
(da)
|
2002-08-02 |
2007-12-03 |
Ab Science |
2-(3-aminoaryl)amino-4-aryl-thiazoler til sygdomsbehandling
|
ATE454378T1
(de)
|
2002-11-01 |
2010-01-15 |
Vertex Pharma |
Verbindungen, die sich als inhibitoren vonjak und anderen proteinkinasen eignen
|
CA2506773A1
(en)
|
2002-11-04 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyramidine derivatives as jak inhibitors
|
AU2003286895A1
(en)
|
2002-11-05 |
2004-06-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of jak and other protein kinases
|
US7098332B2
(en)
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
JPWO2004080462A1
(ja)
|
2003-03-10 |
2006-06-08 |
エーザイ株式会社 |
c−Kitキナーゼ阻害剤
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
JP4836788B2
(ja)
|
2003-07-23 |
2011-12-14 |
エグゼリクシス, インコーポレイテッド |
未分化リンパ腫キナーゼ変調因子及びその使用法
|
US20050026933A1
(en)
|
2003-08-01 |
2005-02-03 |
Wyeth Holdings Corporation |
Use of a combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
|
JP4607879B2
(ja)
|
2003-08-15 |
2011-01-05 |
ノバルティス アーゲー |
新生物疾患、炎症および免疫障害の処置に有用な2,4−ピリミジンジアミン
|
UA84712C2
(en)
|
2003-08-21 |
2008-11-25 |
Оси Фармасьютикалз, Инк. |
N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
|
WO2005021544A2
(en)
|
2003-08-21 |
2005-03-10 |
Osi Pharmaceuticals, Inc. |
N3-substituted imidazopyridine-derivatives as c-kit inhibitors
|
BRPI0413746A
(pt)
|
2003-08-21 |
2006-10-24 |
Osi Pharm Inc |
composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo
|
US7538120B2
(en)
|
2003-09-03 |
2009-05-26 |
Array Biopharma Inc. |
Method of treating inflammatory diseases
|
US7144907B2
(en)
|
2003-09-03 |
2006-12-05 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
DE10342794A1
(de)
|
2003-09-16 |
2005-04-21 |
Basf Ag |
Sekretion von Proteinen aus Hefen
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
JP4931419B2
(ja)
|
2003-09-19 |
2012-05-16 |
中外製薬株式会社 |
新規4−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用
|
JP2007505938A
(ja)
|
2003-09-23 |
2007-03-15 |
ノバルティス アクチエンゲゼルシャフト |
Vegf受容体阻害剤と化学療法剤の組み合わせ
|
UA83509C2
(en)
|
2003-10-15 |
2008-07-25 |
Оси Фармасьютикалз, Инк. |
Imidazopyrazines as tyrosine kinase inhibitors
|
EP1526177A1
(en)
|
2003-10-24 |
2005-04-27 |
Institut Curie |
Nucleic acids useful for triggering tumor cell lethality
|
US7476729B2
(en)
|
2003-10-24 |
2009-01-13 |
Institut Curie |
Dbait and uses thereof
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
DK1689233T3
(da)
|
2003-11-19 |
2012-10-15 |
Array Biopharma Inc |
Bicykliske inhibitorer af MEK
|
DE102004001607A1
(de)
|
2004-01-09 |
2005-08-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern
|
WO2005073225A1
(en)
|
2004-01-30 |
2005-08-11 |
Ab Science |
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
|
NZ547517A
(en)
|
2004-02-27 |
2009-04-30 |
Eisai R&D Man Co Ltd |
Novel pyridine and pyrimidine derivatives for hepatocyte growth and tumour inihibition
|
ATE508129T1
(de)
|
2004-03-30 |
2011-05-15 |
Vertex Pharma |
Als inhibitoren von jak und anderen proteinkinasen geeignete azaindole
|
FR2868422B1
(fr)
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
CN102924458B
(zh)
|
2004-04-02 |
2014-11-05 |
Osi制药有限责任公司 |
6,6-双环取代的杂双环蛋白激酶抑制剂
|
MXPA06014696A
(es)
|
2004-06-15 |
2007-02-12 |
Astrazeneca Ab |
Quinazolonas sustituidas como agentes anticancerosos.
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
JP5704785B2
(ja)
|
2004-07-19 |
2015-04-22 |
ザ・ジョンズ・ホプキンス・ユニバーシティ |
免疫抑制のためのflt3阻害剤
|
MY144232A
(en)
|
2004-07-26 |
2011-08-15 |
Chugai Pharmaceutical Co Ltd |
5-substituted-2-phenylamino benzamides as mek inhibitors
|
WO2007040469A2
(en)
|
2005-09-15 |
2007-04-12 |
Kosak Ken M |
Chloroquine coupled compositions and methods for their synthesis
|
CA2577275A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
MX2007002433A
(es)
|
2004-09-01 |
2007-05-04 |
Astrazeneca Ab |
Derivados de quinazolinona y su uso como inhibidores de b-raf.
|
ZA200702645B
(en)
|
2004-09-17 |
2008-08-27 |
Vertex Pharma |
Diaminotriazole compounds useful as protein kinase inhibitors
|
AU2005293384A1
(en)
|
2004-10-15 |
2006-04-20 |
Astrazeneca Ab |
Quinoxalines as B Raf inhibitors
|
US20070293544A1
(en)
|
2004-11-24 |
2007-12-20 |
Ulrich Abel |
Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders
|
EP1885352A2
(en)
|
2004-11-24 |
2008-02-13 |
Novartis AG |
Combinations comprising jak inhibitors and at least one of bcr-abl, flt-3, fak or raf kinase inhibitors
|
WO2006060381A2
(en)
|
2004-12-01 |
2006-06-08 |
Osi Pharmaceuticals, Inc. |
N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
|
DE602005016718D1
(de)
|
2004-12-01 |
2009-10-29 |
Merck Serono Sa Coinsins |
Ä1,2,4ütriazoloä4,3-aüpyridin-derivative zur behandlung hyperproliferativer erkrankungen
|
CA2589773A1
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Pyridine carboxamide derivatives for use as anticancer agents
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
AU2006208834A1
(en)
|
2005-01-25 |
2006-08-03 |
Astrazeneca Ab |
Chemical compounds
|
WO2006080450A1
(ja)
|
2005-01-27 |
2006-08-03 |
Kyowa Hakko Kogyo Co., Ltd. |
Igf-1r阻害剤
|
PT2383268E
(pt)
|
2005-02-04 |
2015-12-21 |
Astrazeneca Ab |
Derivados de pirazolilaminopiridina úteis como inibidores de quinase
|
PT1853588E
(pt)
|
2005-02-16 |
2008-08-25 |
Astrazeneca Ab |
Compostos químicos
|
MX2007009842A
(es)
|
2005-02-16 |
2007-08-23 |
Astrazeneca Ab |
Compuestos quimicos.
|
NZ561000A
(en)
|
2005-02-28 |
2010-01-29 |
Japan Tobacco Inc |
Novel aminopyridine compound with Syk inhibitory activity
|
AU2006229343A1
(en)
|
2005-03-28 |
2006-10-05 |
Kirin Pharma Kabushiki Kaisha |
Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
|
KR20080019578A
(ko)
|
2005-04-04 |
2008-03-04 |
에이비 사이언스 |
치환된 옥사졸 유도체 및 이의 티로신 키나제 억제제로서의용도
|
KR20080011199A
(ko)
|
2005-04-19 |
2008-01-31 |
교와 핫꼬 고교 가부시끼가이샤 |
질소 함유 복소환 화합물
|
KR20080015409A
(ko)
|
2005-05-16 |
2008-02-19 |
아스트라제네카 아베 |
티로신 키나제 억제제로서 유용한 피라졸릴아미노피리미딘 유도체
|
ES2333182T3
(es)
|
2005-05-18 |
2010-02-17 |
Array Biopharma, Inc. |
Derivados de 4-(fenilamino)-6-oxo-1,6-dihidropiridazina-3-carboxamida como inhibidores de mek para el tratamiento de enfermedades hiperproliferativas.
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
WO2006133417A1
(en)
|
2005-06-07 |
2006-12-14 |
Valeant Pharmaceuticals International |
Phenylamino isothiazole carboxamidines as mek inhibitors
|
US20070021435A1
(en)
|
2005-06-10 |
2007-01-25 |
Gaul Michael D |
Aminopyrimidines as kinase modulators
|
ATE524445T1
(de)
|
2005-06-23 |
2011-09-15 |
Merck Sharp & Dohme |
Benzocycloheptapyridine als inhibitoren der tyrosinkinase met
|
TW200738638A
(en)
|
2005-06-23 |
2007-10-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
TW200740820A
(en)
|
2005-07-05 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Fused heterocyclic derivatives and use thereof
|
EP1904065A2
(en)
|
2005-07-14 |
2008-04-02 |
AB Science |
Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma
|
JP5071374B2
(ja)
|
2005-07-14 |
2012-11-14 |
アステラス製薬株式会社 |
ヘテロ環ヤヌスキナーゼ3阻害剤
|
WO2007028445A1
(en)
|
2005-07-15 |
2007-03-15 |
Glaxo Group Limited |
6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
|
PE20070362A1
(es)
|
2005-07-15 |
2007-04-23 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE INDAZOL-4-IL-2,4-PIRIMIDINDIAMINA COMO INHIBIDORES DE TIROSINA QUINASA (QUINASA Syk)
|
PL1912636T3
(pl)
|
2005-07-21 |
2015-02-27 |
Ardea Biosciences Inc |
N-(aryloamino)sulfonamidowe inhibitory mek
|
NZ566793A
(en)
|
2005-08-24 |
2010-03-26 |
Eisai R&D Man Co Ltd |
Novel pyridine derivative and pyrimidine derivative
|
EP1922310A2
(en)
|
2005-09-07 |
2008-05-21 |
Rigel Pharmaceuticals, Inc. |
Triazole derivatives useful as axl inhibitors
|
FR2891273B1
(fr)
|
2005-09-27 |
2007-11-23 |
Aventis Pharma Sa |
NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
|
RU2436776C2
(ru)
|
2005-09-27 |
2011-12-20 |
Айрм Ллк |
ДИАРИЛАМИН-СОДЕРЖАЩИЕ СОЕДИНЕНИЯ, КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРОВ с-КIT
|
EA025871B9
(ru)
|
2005-10-07 |
2017-08-31 |
Экселиксис, Инк. |
Ингибиторы mek и способы их применения
|
EA200800664A1
(ru)
|
2005-10-13 |
2009-02-27 |
Глаксо Груп Лимитед |
Производные пирролопиримидина в качестве ингибиторов syk
|
EP1963302B1
(en)
|
2005-12-05 |
2013-02-27 |
Pfizer Products Inc. |
Polymorphs of a c-met/hgfr inhibitor
|
PT3184526T
(pt)
|
2005-12-13 |
2018-12-19 |
Incyte Holdings Corp |
Derivados de pirrolo[2,3-d]pirimidina como inibidores da cinase janus
|
WO2007075554A2
(en)
|
2005-12-19 |
2007-07-05 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
EP1966155A1
(en)
|
2005-12-21 |
2008-09-10 |
AstraZeneca AB |
Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer
|
WO2007071963A2
(en)
|
2005-12-22 |
2007-06-28 |
Astrazeneca Ab |
Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
|
BRPI0722364A2
(pt)
|
2006-01-17 |
2011-08-16 |
Vertex Pharma |
azaindóis, composição farmacêutica e usos dos referidos compostos
|
FR2896504B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
FR2896503B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
WO2007085540A1
(en)
|
2006-01-27 |
2007-08-02 |
Glaxo Group Limited |
1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
|
GB0601962D0
(en)
|
2006-01-31 |
2006-03-15 |
Ucb Sa |
Therapeutic agents
|
TW200740776A
(en)
|
2006-02-06 |
2007-11-01 |
Osi Pharm Inc |
N-phenylbenzotriazolyl c-kit inhibitors
|
EP2004625B1
(en)
|
2006-03-22 |
2009-12-30 |
Vertex Pharmaceuticals Incorporated |
C-met protein kinase inhibitors for the treatment of proliferative disorders
|
WO2007113558A2
(en)
|
2006-04-05 |
2007-10-11 |
Astrazeneca Ab |
Quinazolinone derivatives having b-raf inhibitory activity
|
AU2007235487A1
(en)
|
2006-04-05 |
2007-10-18 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of janus kinases
|
EP2007736A1
(en)
|
2006-04-05 |
2008-12-31 |
AstraZeneca AB |
Substituted quinazolines with anti-cancer activity
|
US20090203718A1
(en)
|
2006-04-13 |
2009-08-13 |
Smithkline Beecham (Cork) Ltd. |
Cancer treatment method
|
CN101454004B
(zh)
|
2006-04-18 |
2013-12-04 |
阿迪亚生命科学公司 |
作为mek抑制剂的吡啶酮磺酰胺类和吡啶酮硫酰胺类
|
EP2010504A1
(en)
|
2006-04-18 |
2009-01-07 |
AstraZeneca AB |
Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
|
JP5525812B2
(ja)
|
2006-04-19 |
2014-06-18 |
メルク セローノ ソシエテ アノニム |
Mekインヒビターとしての新規ヘテロアリール置換アリールアミノピリジン誘導体
|
KR20090004976A
(ko)
|
2006-04-19 |
2009-01-12 |
아스테라스 세이야쿠 가부시키가이샤 |
아졸카르복사미드 유도체
|
EP2015748B1
(en)
|
2006-04-20 |
2012-07-04 |
Janssen Pharmaceutica NV |
A C-Kit kinase inhibitor for use in the treatment of gastrointestinal stromal tumor or mastocytosis
|
ES2542344T3
(es)
|
2006-05-09 |
2015-08-04 |
Novaremed Ltd. |
Uso de inhibidores de tirosina cinasa Syk para el tratamiento de trastornos proliferativos celulares
|
RU2448708C3
(ru)
|
2006-05-18 |
2017-09-28 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Противоопухолевое средство против рака щитовидной железы
|
WO2008005877A2
(en)
|
2006-06-30 |
2008-01-10 |
Board Of Regents, The University Of Texas System |
Inhibitors of c-kit and uses thereof
|
TW200813021A
(en)
|
2006-07-10 |
2008-03-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
ATE456392T1
(de)
|
2006-07-20 |
2010-02-15 |
Amgen Inc |
Benzoädüisoxazol-derivate als c-kit-tyrosinkinase-hemmer zur behandlung von erkrankungen im zusammenhang mit der überproduktion von histamin
|
US8044049B2
(en)
|
2006-08-04 |
2011-10-25 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic derivative and use thereof
|
WO2008020203A1
(en)
|
2006-08-17 |
2008-02-21 |
Astrazeneca Ab |
Pyridinylquinaz0linamine derivatives and their use as b-raf inhibitors
|
ES2375284T3
(es)
|
2006-08-23 |
2012-02-28 |
Eisai R&D Management Co., Ltd. |
Sal de un derivado de fenoxipiridina, o cristal de la misma, y procedimiento de producción de la misma.
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
PT2526933E
(pt)
|
2006-09-22 |
2015-06-23 |
Pharmacyclics Inc |
Inibidores da tirosina-quinase de bruton
|
WO2008045978A1
(en)
|
2006-10-10 |
2008-04-17 |
Rigel Pharmaceuticals, Inc. |
Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors
|
CN101558068A
(zh)
|
2006-10-16 |
2009-10-14 |
诺瓦提斯公司 |
用作蛋白激酶抑制剂的苯乙酰胺类
|
EP2108642A1
(en)
|
2006-10-17 |
2009-10-14 |
Kyowa Hakko Kirin Co., Ltd. |
Jak inhibitor
|
TW200829566A
(en)
|
2006-12-08 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
WO2008076415A1
(en)
|
2006-12-14 |
2008-06-26 |
Exelixis, Inc. |
Methods of using mek inhibitors
|
WO2008076143A1
(en)
|
2006-12-18 |
2008-06-26 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
CN101679408B
(zh)
|
2006-12-22 |
2016-04-27 |
Astex治疗学有限公司 |
作为fgfr抑制剂的双环杂环化合物
|
WO2008080134A2
(en)
|
2006-12-22 |
2008-07-03 |
Rigel Pharmaceuticals, Inc. |
4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
|
PT2078010E
(pt)
|
2006-12-29 |
2014-05-07 |
Rigel Pharmaceuticals Inc |
Triazoles substituídos com heteroarilos policíclicos úteis como inibidores de axl
|
US7872000B2
(en)
|
2006-12-29 |
2011-01-18 |
Rigel Pharmaceuticals, Inc. |
Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
|
US8012965B2
(en)
|
2006-12-29 |
2011-09-06 |
Rigel Pharmaceuticals, Inc. |
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
JP2010514810A
(ja)
|
2006-12-29 |
2010-05-06 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Axlインヒビターとして有用な置換トリアゾール
|
CN101622248B
(zh)
|
2006-12-29 |
2013-04-17 |
里格尔制药公司 |
用作axl抑制剂的n3-杂芳基取代的三唑和n5-杂芳基取代的三唑
|
EP1944369A1
(en)
|
2007-01-12 |
2008-07-16 |
The Centre National de la Recherche Scientifique |
Dbait and its standalone uses thereof
|
BRPI0806898A2
(pt)
|
2007-01-19 |
2015-07-14 |
Ardea Biosciences Inc |
Inibidores de mek
|
US8168415B2
(en)
|
2007-02-07 |
2012-05-01 |
The Regents Of The University Of Colorado |
Axl fusion proteins as Axl tyrosine kinase inhibitors
|
KR20090090365A
(ko)
|
2007-02-23 |
2009-08-25 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
Hgfr 유전자 증폭 세포주에 대하여 우수한 세포 증식 억제 효과 및 항종양 효과를 나타내는 피리딘 유도체 또는 피리미딘 유도체
|
EP2133095A4
(en)
|
2007-03-05 |
2012-09-26 |
Kyowa Hakko Kirin Co Ltd |
PHARMACEUTICAL COMPOSITION
|
MX2009009792A
(es)
|
2007-03-12 |
2009-09-23 |
Cytopia Res Pty Ltd |
Compuestos de fenil amino pirimidina y usos de los mismos.
|
AU2008228768A1
(en)
|
2007-03-22 |
2008-09-25 |
Vertex Pharmaceuticals Incorporated |
N-heterocyclic compounds useful as inhibitors of Janus Kinases
|
IL295053A
(en)
|
2007-03-28 |
2022-09-01 |
Pharmacyclics Llc |
Broton tyrosine kinase inhibitors
|
AU2008240188A1
(en)
|
2007-04-13 |
2008-10-23 |
Supergen, Inc. |
Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
GB0714384D0
(en)
|
2007-07-23 |
2007-09-05 |
Ucb Pharma Sa |
theraputic agents
|
CA2924436A1
(en)
|
2007-07-30 |
2009-02-05 |
Ardea Biosciences, Inc. |
Pharmaceutical combinations of n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide as inhibitors of mek and methods of use
|
CN103479604B
(zh)
|
2007-07-30 |
2016-08-10 |
阿迪生物科学公司 |
作为mek抑制剂的包括多晶型物的n-(芳氨基)磺酰胺衍生物和组合物、其使用方法和制备方法
|
PA8792501A1
(es)
|
2007-08-09 |
2009-04-23 |
Sanofi Aventis |
Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
|
RU2458925C2
(ru)
|
2007-09-05 |
2012-08-20 |
Райджел Фармасьютикалз, Инк. |
Ксинафоатная соль n4-[(2,2-дифтор-4н-бензо[1,4]оксазин-3-он)-6-ил]-5-фтор-n2-[3-(метиламинокарбонилметиленокси)фенил]-2,4-пиримидиндиамина
|
CN101835755B
(zh)
|
2007-10-23 |
2013-12-11 |
霍夫曼-拉罗奇有限公司 |
激酶抑制剂
|
WO2009054468A1
(ja)
|
2007-10-24 |
2009-04-30 |
Astellas Pharma Inc. |
アゾールカルボキサミド化合物又はその塩
|
SI2205592T1
(sl)
|
2007-10-26 |
2013-09-30 |
Rigel Pharmaceuticals, Inc. |
Triazoli substituirani s policikličnim arilom in triazoli substituirani s policikličnim heteroarilom uporabni kot Axl inhibitorji
|
CA2703600C
(en)
|
2007-11-15 |
2017-04-25 |
Ym Biosciences Australia Pty Ltd |
Fused thieno or pyrrolo pyrimidine heterocyclic compounds and use thereof as jak1, jak2, and/or jak3 inhibitors
|
US20110039856A1
(en)
|
2007-11-29 |
2011-02-17 |
Pfizer Inc. |
Polymorphs of a c-met/hgfr inhibitor
|
WO2009093008A1
(en)
|
2008-01-21 |
2009-07-30 |
Ucb Pharma S.A. |
Thieno-pyridine derivatives as mek inhibitors
|
GB0801416D0
(en)
|
2008-01-25 |
2008-03-05 |
Piramed Ltd |
Pharmaceutical compounds
|
US8436171B2
(en)
|
2008-02-01 |
2013-05-07 |
Akinion Pharmaceuticals Ab |
Amino substituted pyrazines as inhibitors or protein kinases
|
WO2009098144A1
(en)
|
2008-02-05 |
2009-08-13 |
F. Hoffmann-La Roche Ag |
Novel pyridinones and pyridazinones
|
ATE551342T1
(de)
|
2008-02-22 |
2012-04-15 |
Irm Llc |
Heterocyclische verbindungen und zusammensetzungen als c-kit- und pdgfr- kinasehemmer
|
CL2009000447A1
(es)
|
2008-02-29 |
2010-01-04 |
Array Biopharma Inc Y Genentech Inc |
Compuestos derivados de (1h-pirrolo{2,3-b}piridin-5-il)-sulfonamido-benzamida sustituida; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento del cancer, a travez de la inhibicion de raf.
|
WO2009111280A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
|
US20110003809A1
(en)
|
2008-02-29 |
2011-01-06 |
Array Biopharma Inc. |
Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
|
AU2009222144A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
Pyrazole [3, 4-b] pyridine Raf inhibitors
|
TWI444382B
(zh)
|
2008-03-11 |
2014-07-11 |
Incyte Corp |
作為jak抑制劑之氮雜環丁烷及環丁烷衍生物
|
AU2009226153B2
(en)
|
2008-03-19 |
2014-02-20 |
Chembridge Corporation |
Novel tyrosine kinase inhibitors
|
US8822500B2
(en)
|
2008-03-19 |
2014-09-02 |
Chembridge Corporation |
Tyrosine kinase inhibitors
|
JP5788312B2
(ja)
|
2008-04-11 |
2015-09-30 |
アルニラム ファーマスーティカルズ インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
標的リガンドをエンドソーム分解性成分と組み合わせることによる核酸の部位特異的送達
|
EP2291350A4
(en)
|
2008-04-14 |
2012-09-19 |
Ardea Biosciences Inc |
COMPOSITIONS AND METHODS FOR THEIR MANUFACTURE AND USE
|
EP2262772B8
(en)
|
2008-04-16 |
2013-03-13 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Quinoline derivatives as axl kinase inhibitors
|
JP5705720B2
(ja)
|
2008-04-16 |
2015-04-22 |
ポートラ ファーマシューティカルズ, インコーポレイテッド |
Sykまたはjakキナーゼ阻害剤としての2,6−ジアミノ−ピリミジン−5−イル−カルボキサミド
|
KR101773313B1
(ko)
|
2008-04-16 |
2017-08-31 |
포톨라 파마슈티컬스, 인코포레이티드 |
syk 또는 JAK 키나제 억제제로서의 2,6-디아미노-피리미딘-5-일-카르복스아미드
|
AU2009238590A1
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
JP2011518836A
(ja)
|
2008-04-24 |
2011-06-30 |
インサイト・コーポレイション |
大環状化合物およびそれらのキナーゼ阻害剤としての使用
|
TWI472529B
(zh)
|
2008-05-21 |
2015-02-11 |
Incyte Corp |
2-氟-N-甲基-4-〔7-(喹啉-6-基-甲基)-咪唑并〔1,2-b〕〔1,2,4〕三-2-基〕苯甲醯胺之鹽類及其相關製備方法
|
LT2300013T
(lt)
|
2008-05-21 |
2017-12-27 |
Ariad Pharmaceuticals, Inc. |
Fosforo dariniai kaip kinazių inhibitoriai
|
JP2011524888A
(ja)
|
2008-06-19 |
2011-09-08 |
アストラゼネカ アクチボラグ |
ピラゾール化合物436
|
GB0811304D0
(en)
|
2008-06-19 |
2008-07-30 |
Ucb Pharma Sa |
Therapeutic agents
|
JP5595389B2
(ja)
|
2008-06-20 |
2014-09-24 |
ジェネンテック, インコーポレイテッド |
トリアゾロピリジンjak阻害剤化合物と方法
|
CA2727036C
(en)
|
2008-06-20 |
2017-03-21 |
Genentech, Inc. |
Triazolopyridine jak inhibitor compounds and methods
|
UA103327C2
(en)
|
2008-06-24 |
2013-10-10 |
Ф. Хоффманн-Ля Рош Аг |
Substituted pyridin-2-ones and pyridazin-3-ones
|
JP5613156B2
(ja)
|
2008-07-09 |
2014-10-22 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Axl阻害剤として有用な架橋二環ヘテロアリール置換トリアゾール
|
US8349838B2
(en)
|
2008-07-09 |
2013-01-08 |
Rigel Pharmaceuticals, Inc. |
Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
|
AU2009270856B2
(en)
|
2008-07-16 |
2013-07-25 |
Pharmacyclics Llc |
Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
|
CN102159559A
(zh)
|
2008-07-18 |
2011-08-17 |
赛诺菲-安万特 |
新型咪唑并[1,2-a]吡啶衍生物、其制备方法、其作为药物的用途、其药物组合物和新型用途特别是作为MET抑制剂的新型用途
|
FR2933982A1
(fr)
|
2008-07-18 |
2010-01-22 |
Sanofi Aventis |
Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
|
MX2011000671A
(es)
|
2008-07-18 |
2011-04-11 |
Sanofi Aventis |
Nuevos derivados de triazolo [4,3-a] piridina su procedimiento de preparacion, su uso como medicamentos, composiciones farmaceuticas y nuevo uso particularmente como inhibidores de met.
|
PT2307376E
(pt)
|
2008-08-04 |
2016-02-26 |
Merck Patent Gmbh |
Novos compostos de fenilamino-isonicotinamida
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
CN103965200B
(zh)
|
2008-09-22 |
2016-06-08 |
阵列生物制药公司 |
作为trk激酶抑制剂的取代的咪唑并[1,2-b]哒嗪化合物
|
LT3372605T
(lt)
|
2008-10-22 |
2022-02-10 |
Array Biopharma, Inc. |
Pakeistieji pirazolo[1,5-a]pirimidino junginiai, kaip trk kinazės inhibitoriai
|
BRPI0914404A2
(pt)
|
2008-10-31 |
2019-03-06 |
Genentech Inc |
"compostos, composição farmacêutica e método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak quinase em um paciente"
|
EP2365970B1
(en)
|
2008-11-12 |
2018-03-21 |
Gilead Connecticut, Inc. |
Pyridazinones and their use as btk inhibitors
|
NZ592825A
(en)
|
2008-11-19 |
2013-01-25 |
Vertex Pharma |
A triazolothiadiazole inhibitor of c-met protein kinase
|
PE20140975A1
(es)
|
2008-12-08 |
2014-08-25 |
Gilead Connecticut Inc |
Derivados de imidazopirazina como inhibidores de syk
|
ES2744541T3
(es)
|
2008-12-08 |
2020-02-25 |
Gilead Connecticut Inc |
Inhibidores de imidazopirazina Syk
|
ITMI20082336A1
(it)
|
2008-12-29 |
2010-06-30 |
Univ Parma |
Composti inibitori irreversibili di egfr con attivita' antiproliferativa
|
EP2376481B1
(en)
|
2009-01-13 |
2013-08-07 |
Glaxo Group Limited |
Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
|
JOP20190231A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
AU2010204578B2
(en)
|
2009-01-16 |
2016-05-12 |
Rigel Pharmaceuticals, Inc. |
AXL inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
|
WO2010085597A1
(en)
|
2009-01-23 |
2010-07-29 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
FR2941952B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
FR2941951B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
EP2393814A1
(en)
|
2009-02-09 |
2011-12-14 |
SuperGen, Inc. |
Pyrrolopyrimidinyl axl kinase inhibitors
|
WO2010108652A1
(en)
|
2009-03-27 |
2010-09-30 |
Ardea Biosciences Inc. |
Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
|
CA2761108A1
(en)
|
2009-04-21 |
2010-10-28 |
Novartis Ag |
Heterocyclic compounds as mek inhibitors
|
JP5656976B2
(ja)
|
2009-04-29 |
2015-01-21 |
ローカス ファーマシューティカルズ インコーポレイテッド |
ピロロトリアジン化合物
|
EP2440559B1
(en)
|
2009-05-05 |
2018-01-10 |
Dana-Farber Cancer Institute, Inc. |
Egfr inhibitors and methods of treating disorders
|
CN106967070A
(zh)
|
2009-05-22 |
2017-07-21 |
因塞特控股公司 |
作为jak抑制剂的化合物
|
SG175707A1
(en)
|
2009-06-10 |
2011-12-29 |
Chugai Pharmaceutical Co Ltd |
Tetracyclic compound
|
AR077033A1
(es)
|
2009-06-11 |
2011-07-27 |
Hoffmann La Roche |
Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
|
ES2632220T3
(es)
|
2009-06-15 |
2017-09-11 |
Rigel Pharmaceuticals, Inc. |
Inhibidores de moléculas pequeñas de tirosina cinasa del bazo (SYK)
|
CN102134218A
(zh)
|
2009-06-15 |
2011-07-27 |
凯美隆(北京)药业技术有限公司 |
6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
TW201105669A
(en)
|
2009-07-30 |
2011-02-16 |
Irm Llc |
Compounds and compositions as Syk kinase inhibitors
|
CN102574847A
(zh)
|
2009-07-30 |
2012-07-11 |
Irm责任有限公司 |
作为syk激酶抑制剂的化合物和组合物
|
JP2013503193A
(ja)
|
2009-08-28 |
2013-01-31 |
ジェネンテック, インコーポレイテッド |
Raf阻害剤化合物およびその使用方法
|
WO2011025968A1
(en)
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
1h-pyrazolo [ 3, 4-b] pyridine compounds for inhibiting raf kinase
|
JP2013503187A
(ja)
|
2009-08-28 |
2013-01-31 |
アレイ バイオファーマ、インコーポレイテッド |
Raf阻害化合物およびその使用方法
|
US20120157451A1
(en)
|
2009-08-28 |
2012-06-21 |
Genentech, Inc |
Raf inhibitor compounds and methods of use thereof
|
JP5699149B2
(ja)
|
2009-09-04 |
2015-04-08 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Bruton型チロシンキナーゼ阻害薬
|
WO2011029043A1
(en)
|
2009-09-04 |
2011-03-10 |
Biogen Idec Ma Inc. |
Heteroaryl btk inhibitors
|
WO2011039527A1
(en)
|
2009-09-30 |
2011-04-07 |
Merck Sharp & Dohme Ltd |
Formulations for c-met kinase inhibitors
|
WO2011047055A2
(en)
|
2009-10-13 |
2011-04-21 |
Allostem Therapeutics Llc |
Novel mek inhibitors, useful in the treatment of diseases
|
UA105064C2
(uk)
|
2009-10-16 |
2014-04-10 |
Ґлаксосмітклайн Ллк |
КОМБІНАЦІЯ, ЩО МІСТИТЬ ІНГІБІТОР МЕК ТА ІНГІБІТОР В-Raf
|
EA201200651A1
(ru)
|
2009-11-04 |
2012-12-28 |
Новартис Аг |
Гетероциклические сульфонамидные производные, применимые в качестве ингибиторов мек
|
EP2512246B1
(en)
|
2009-12-17 |
2015-09-30 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
AU2010331927B2
(en)
|
2009-12-17 |
2013-10-10 |
Merck Canada Inc. |
Aminopyrimidines as Syk inhibitors
|
AU2010336533B9
(en)
|
2009-12-23 |
2015-10-08 |
Arqule, Inc. |
Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
|
PL2516434T3
(pl)
|
2009-12-23 |
2015-11-30 |
Takeda Pharmaceuticals Co |
Skondensowane heteroaromatyczne pirolidynony jako inhibitory SYK
|
EP2338888A1
(en)
|
2009-12-24 |
2011-06-29 |
Almirall, S.A. |
Imidazopyridine derivatives as JAK inhibitors
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
EP2523952B1
(en)
|
2010-01-12 |
2015-03-04 |
AB Science |
Oxazole kinase inhibitors
|
NZ600857A
(en)
|
2010-01-29 |
2014-06-27 |
Boehringer Ingelheim Int |
Substituted naphthyridines and their use as syk kinase inhibitors
|
US9562056B2
(en)
|
2010-03-11 |
2017-02-07 |
Gilead Connecticut, Inc. |
Imidazopyridines Syk inhibitors
|
US8481541B2
(en)
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
ES2677356T3
(es)
|
2010-03-24 |
2018-08-01 |
Amitech Therapeutics Solutions, Inc. |
Compuestos heterocíclicos útiles para la inhibición de quinasas
|
TW201202242A
(en)
|
2010-03-30 |
2012-01-16 |
Sanofi Aventis |
6-(alkyl-or cycloalkyl-triazolopyridazine-sulfanyl)benzo-thiazole derivatives: preparation, and use as medicaments and as MET inhibitors
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
WO2011138751A2
(en)
|
2010-05-04 |
2011-11-10 |
Pfizer Inc. |
Heterocyclic derivatives as alk inhibitors
|
US20130072495A1
(en)
|
2010-05-14 |
2013-03-21 |
OSI Pharmaceuticals, LLC |
Fused bicyclic kinase inhibitors
|
CN102906095A
(zh)
|
2010-05-20 |
2013-01-30 |
弗·哈夫曼-拉罗切有限公司 |
作为syk和jak抑制剂的吡咯并吡嗪衍生物
|
CA2799904A1
(en)
|
2010-05-20 |
2011-11-24 |
F. Hoffmann-La Roche Ag |
Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
|
WO2011149878A1
(en)
|
2010-05-27 |
2011-12-01 |
Vertex Pharmaceuticals Incorporated |
An aminopyrazole triazolothiadiazole inhibitor of c-met protein kinase
|
EP2576566B1
(en)
|
2010-05-28 |
2015-10-28 |
Merck Sharp & Dohme B.V. |
Thieno(2,3b)pyrazine compounds as b-raf inhibitors
|
PL2578585T3
(pl)
|
2010-05-31 |
2017-01-31 |
Ono Pharmaceutical Co., Ltd. |
Pochodna purynonu jako inhibitor kinazy btk
|
EA201890869A3
(ru)
|
2010-06-03 |
2019-03-29 |
Фармасайкликс, Инк. |
Применение ингибиторов тирозинкиназы брутона (btk)
|
CA2802463C
(en)
|
2010-06-22 |
2019-02-26 |
Dna Therapeutics |
Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
|
MX2012015023A
(es)
|
2010-06-30 |
2013-04-03 |
Fujifilm Corp |
Derivado novedoso de nicotinamida o sal del mismo.
|
JPWO2012005299A1
(ja)
|
2010-07-07 |
2013-09-05 |
日本新薬株式会社 |
Rosチロシンキナーゼ阻害剤
|
SG187064A1
(en)
|
2010-07-14 |
2013-02-28 |
Zhejiang Beta Pharma Inc |
NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
|
WO2012008564A1
(ja)
|
2010-07-16 |
2012-01-19 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
CN103003262A
(zh)
|
2010-07-16 |
2013-03-27 |
协和发酵麒麟株式会社 |
含氮芳香族杂环衍生物
|
AR085183A1
(es)
|
2010-07-30 |
2013-09-18 |
Lilly Co Eli |
Compuesto 6-(1-metil-1h-pirazol-4-il)-3-(2-metil-2h-indazol-5-iltio)-[1,2,4]triazol[4,3-b]piridazina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar cancer
|
TW201219383A
(en)
|
2010-08-02 |
2012-05-16 |
Astrazeneca Ab |
Chemical compounds
|
CN105566229A
(zh)
|
2010-08-10 |
2016-05-11 |
西建阿维拉米斯研究公司 |
Btk抑制剂的苯磺酸盐及其用途和制备方法
|
NZ608312A
(en)
|
2010-08-20 |
2015-02-27 |
Chugai Pharmaceutical Co Ltd |
Composition containing tetracyclic compound
|
EA201300283A1
(ru)
|
2010-08-27 |
2013-08-30 |
Мерк Патент Гмбх |
Производные фуропиридина
|
SG188296A1
(en)
|
2010-08-27 |
2013-04-30 |
Merck Patent Gmbh |
Triazolopyrazine derivatives
|
EP2423208A1
(en)
|
2010-08-28 |
2012-02-29 |
Lead Discovery Center GmbH |
Pharmaceutically active compounds as Axl inhibitors
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
US8664244B2
(en)
|
2010-09-12 |
2014-03-04 |
Advenchen Pharmaceuticals, LLC |
Compounds as c-Met kinase inhibitors
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
BR112013009260A2
(pt)
|
2010-10-08 |
2016-07-26 |
Xcovery Holding Co Llc |
compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase
|
CA2816219C
(en)
|
2010-11-01 |
2019-10-29 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as syk modulators
|
CN102020651B
(zh)
|
2010-11-02 |
2012-07-18 |
北京赛林泰医药技术有限公司 |
6-芳基氨基吡啶酮甲酰胺mek抑制剂
|
CN102532141A
(zh)
|
2010-12-08 |
2012-07-04 |
中国科学院上海药物研究所 |
[1,2,4]三唑并[4,3-b][1,2,4]三嗪类化合物、其制备方法和用途
|
US20130004481A1
(en)
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
JP5959541B2
(ja)
|
2011-02-25 |
2016-08-02 |
ノバルティス アーゲー |
Trk阻害剤としてのピラゾロ[1,5−a]ピリジン
|
JP2014507458A
(ja)
|
2011-03-11 |
2014-03-27 |
グラクソ グループ リミテッド |
Sykインヒビターとしてのピリド[3,4−B]ピラジン誘導体
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
KR20140020972A
(ko)
|
2011-03-28 |
2014-02-19 |
에프. 호프만-라 로슈 아게 |
티아졸로피리미딘 화합물
|
BR112013025387B1
(pt)
|
2011-04-01 |
2021-07-27 |
University Of Utah Research Foundation |
Compostos análogos substituídos da n-fenilpirimidin-2-amina como inibidores da quinase axl, uso dos ditos compostos para o tratamento de um distúrbio de proliferação celular descontrolada, bem como kit compreendendo ditos compostos
|
WO2012135801A1
(en)
|
2011-04-01 |
2012-10-04 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
BR112013025792A2
(pt)
|
2011-04-05 |
2018-04-24 |
Pfizer Ltd |
Inibidores de quinase relacionada à pirrolo[2,3-d] pirimidina tropomisina
|
CA2834043A1
(en)
|
2011-05-04 |
2012-11-08 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
WO2012154520A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as syk inhibitors
|
KR20140028062A
(ko)
|
2011-05-10 |
2014-03-07 |
머크 샤프 앤드 돔 코포레이션 |
Syk 억제제로서의 아미노피리미딘
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
BR112013029201B1
(pt)
|
2011-05-13 |
2022-08-09 |
Array Biopharma Inc |
Compostos de pirrolidinil ureia e pirrolidinil tioureia, seu processo de preparação, seu uso e composições farmacêuticas
|
EP2527440A1
(en)
*
|
2011-05-27 |
2012-11-28 |
Institut Curie |
Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
|
WO2012167423A1
(en)
|
2011-06-08 |
2012-12-13 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as novel syk inhibitors
|
CN102816162B
(zh)
|
2011-06-10 |
2016-04-27 |
中国科学院广州生物医药与健康研究院 |
嘧啶并嘧啶酮类化合物及其药用组合物和应用
|
EA031153B1
(ru)
|
2011-06-10 |
2018-11-30 |
Мерк Патент Гмбх |
Применение пиримидиновых соединений с btk ингибирующей активностью
|
CN102393896B
(zh)
|
2011-07-11 |
2014-08-27 |
成都西谷曙光数字技术有限公司 |
一种简单精确的射频定位系统和方法
|
WO2013009582A1
(en)
|
2011-07-12 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
US20140155406A1
(en)
|
2011-07-19 |
2014-06-05 |
Petrus Antonius De Adrianus Man |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk inhibitors
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
MY192354A
(en)
|
2011-07-19 |
2022-08-17 |
Merck Sharp & Dohme |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors
|
RU2612972C2
(ru)
|
2011-07-27 |
2017-03-14 |
Аб Сьянс |
Селективные ингибиторы протеинкиназ
|
US9226923B2
(en)
|
2011-07-27 |
2016-01-05 |
Nanjing Allgen Pharma Co. Ltd. |
Spirocyclic molecules as protein kinase inhibitors
|
SG2014014369A
(en)
|
2011-09-01 |
2014-09-26 |
Irm Llc |
Compounds and compositions as c-kit kinase inhibitors
|
US9199981B2
(en)
|
2011-09-01 |
2015-12-01 |
Novartis Ag |
Compounds and compositions as C-kit kinase inhibitors
|
BR112014004319A2
(pt)
|
2011-09-01 |
2017-03-14 |
Irm Llc |
compostos e composições como inibidores de c-kit cinase
|
CN103930424A
(zh)
|
2011-09-01 |
2014-07-16 |
Irm责任有限公司 |
作为c-Kit激酶抑制剂的化合物和组合物
|
JP6093768B2
(ja)
|
2011-09-14 |
2017-03-08 |
ニューファーマ, インコーポレイテッド |
特定の化学的実体、組成物、および方法
|
JP5878178B2
(ja)
|
2011-09-30 |
2016-03-08 |
大鵬薬品工業株式会社 |
1,2,4−トリアジン−6−カルボキサミド誘導体
|
US9006444B2
(en)
|
2011-10-05 |
2015-04-14 |
Merck Sharp & Dohme Corp. |
Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
EP2763976B1
(en)
|
2011-10-05 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
US8987456B2
(en)
|
2011-10-05 |
2015-03-24 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
UA111382C2
(uk)
|
2011-10-10 |
2016-04-25 |
Оріон Корпорейшн |
Інгібітори протеїнкінази
|
JP6506555B2
(ja)
|
2011-10-19 |
2019-04-24 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼ(Btk)阻害剤の使用
|
JP6173327B2
(ja)
|
2011-11-01 |
2017-08-02 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
イミダゾピリダジン化合物
|
CA2853967A1
(en)
|
2011-11-03 |
2013-05-10 |
F. Hoffmann-La Roche Ag |
8-fluorophthalazin-1 (2h) -one compounds as inhibitors of btk activity
|
MX2014005289A
(es)
|
2011-11-03 |
2014-05-30 |
Hoffmann La Roche |
Compuestos de piperazina alquilados.
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
SG10201510307WA
(en)
|
2011-11-14 |
2016-01-28 |
Cephalon Inc |
Uracil derivatives as axl and c-met kinase inhibitors
|
BR112014012727B1
(pt)
|
2011-11-29 |
2022-10-25 |
Ono Pharmaceutical Co., Ltd |
Cloridrato de 6-amino-9-[(3r)-1-(2-butinoil)-3-pirrolidinil]-7-(4-fenoxifenil)-7,9-di-hidro-8h-puri- 8-ona e composição farmacêutica
|
CA2858958C
(en)
|
2011-12-12 |
2016-10-04 |
Dr. Reddy's Laboratories Ltd. |
Substituted pyrazolo[1,5-a]pyridine as tropomyosin receptor kinase (trk) inhibitors
|
PL2796460T3
(pl)
|
2011-12-21 |
2018-12-31 |
Jiangsu Hengrui Medicine Co. Ltd. |
Sześcioczłonowa pirolowa heteroarylowa pochodna pierścieniowa, sposób jej otrzymywania i zastosowania medyczne
|
RU2576623C2
(ru)
|
2011-12-28 |
2016-03-10 |
Фуджифилм Корпорэйшн |
Новое производное никотинамида или его соль
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
CA2860548A1
(en)
|
2012-01-10 |
2013-07-18 |
Shaoqing Chen |
Thienopyrimidine compounds
|
KR20140108594A
(ko)
|
2012-01-10 |
2014-09-11 |
에프. 호프만-라 로슈 아게 |
피리다진 아미드 화합물 및 syk 저해제로서의 이의 용도
|
CN103204822B
(zh)
|
2012-01-17 |
2014-12-03 |
上海科州药物研发有限公司 |
作为蛋白激酶抑制剂的苯并噁唑化合物及其制备方法和用途
|
CN103204844A
(zh)
|
2012-01-17 |
2013-07-17 |
上海艾力斯医药科技有限公司 |
氨基杂芳基化合物及其制备方法与应用
|
PT2657233E
(pt)
|
2012-01-19 |
2014-10-24 |
Taiho Pharmaceutical Co Ltd |
Composto de alcinil-benzeno substituído nas posições 3 e 5 e um seu sal
|
JP6062962B2
(ja)
|
2012-01-20 |
2017-01-18 |
ジェノスコ |
置換ピリミジン化合物およびsyk阻害剤としてのそれらの使用
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
NZ627586A
(en)
|
2012-01-31 |
2016-08-26 |
Daiichi Sankyo Co Ltd |
Pyridone derivatives
|
ES2674451T3
(es)
|
2012-02-21 |
2018-06-29 |
Merck Patent Gmbh |
2-amino-[1,2,4]triazolo[1,5-a] pirazinas 8-sustituidos como inhibidores de la SYK tirosina quinasa e inhibidores de la serina quinasa GCN2
|
ES2606638T3
(es)
|
2012-02-21 |
2017-03-24 |
Merck Patent Gmbh |
Derivados de furopiridina
|
WO2013126132A1
(en)
|
2012-02-21 |
2013-08-29 |
Merck Patent Gmbh |
Cyclic diaminopyrimidine derivatives
|
WO2013124869A2
(en)
|
2012-02-21 |
2013-08-29 |
Amrita Vishwa Vidyapeetham University |
The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
|
EP2821402B1
(en)
|
2012-02-28 |
2019-08-21 |
Astellas Pharma Inc. |
Nitrogen-containing aromatic heterocyclic compound
|
SG11201405007QA
(en)
|
2012-03-14 |
2014-10-30 |
Lupin Ltd |
Heterocyclyl compounds
|
WO2013138495A1
(en)
|
2012-03-15 |
2013-09-19 |
Celgene Avilomics Research, Inc. |
Solid forms of an epidermal growth factor receptor kinase inhibitor
|
AU2013235344B2
(en)
|
2012-03-22 |
2017-03-16 |
Oscotec Inc. |
Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors
|
WO2013148603A1
(en)
|
2012-03-27 |
2013-10-03 |
Takeda Pharmaceutical Company Limited |
Cinnoline derivatives as as btk inhibitors
|
JP6190871B2
(ja)
|
2012-03-30 |
2017-08-30 |
ノバルティス アーゲー |
低リン血症性障害の処置に使用するためのfgfr阻害剤
|
ES2894830T3
(es)
|
2012-04-03 |
2022-02-16 |
Novartis Ag |
Productos combinados con inhibidores de tirosina·cinasa y su uso
|
CN104203242B
(zh)
|
2012-04-04 |
2017-03-15 |
杭州德润玉成生物科技有限公司 |
取代的喹啉类作为布鲁顿酪氨酸激酶抑制剂
|
EP2840080B1
(en)
|
2012-04-17 |
2017-12-06 |
FUJIFILM Corporation |
Nitrogen-containing heterocyclic compound or salt thereof
|
PL2838998T3
(pl)
|
2012-04-18 |
2018-04-30 |
Cell Signaling Technology, Inc. |
EGFR i ROS1 w nowotworze
|
JP6160613B2
(ja)
|
2012-04-26 |
2017-07-12 |
小野薬品工業株式会社 |
Trk阻害化合物
|
US9670213B2
(en)
|
2012-05-14 |
2017-06-06 |
East China University Of Science And Technology |
Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor
|
EP2858501A4
(en)
|
2012-05-22 |
2015-12-09 |
Merck Sharp & Dohme |
TRK-A KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
CA2872645A1
(en)
|
2012-05-30 |
2013-12-05 |
Nippon Shinyaku Co., Ltd. |
Aromatic heterocyclic derivative and pharmaceutical
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并[1,2-b]嗒衍生物
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
PT3495367T
(pt)
|
2012-06-13 |
2020-11-12 |
Incyte Holdings Corp |
Compostos tricíclicos substituídos como inibidores de fgfr
|
KR20150008907A
(ko)
|
2012-06-14 |
2015-01-23 |
일라이 릴리 앤드 캄파니 |
Jak1 및 jak2의 억제제
|
WO2013192125A1
(en)
|
2012-06-20 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as syk inhibitors
|
EP2863913B1
(en)
|
2012-06-20 |
2018-09-12 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
WO2013192088A1
(en)
|
2012-06-22 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
EP2863916B1
(en)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (syk) inhibitors
|
TWI520962B
(zh)
|
2012-06-29 |
2016-02-11 |
|
As the c-Met tyrosine kinase inhibitors novel fused pyridine derivatives
|
CA2782774A1
(en)
|
2012-07-06 |
2014-01-06 |
Pharmascience Inc. |
Protein kinase inhibitors
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
EP2882746B1
(en)
|
2012-08-07 |
2016-12-07 |
Merck Patent GmbH |
Pyridopyrimidine derivatives as protein kinase inhibitors
|
AU2013299557B2
(en)
|
2012-08-10 |
2017-06-22 |
Boehringer Ingelheim International Gmbh |
Heteroaromatic compounds as Bruton's tyrosine kinase (BTK) inhibitors
|
WO2014026125A1
(en)
|
2012-08-10 |
2014-02-13 |
Incyte Corporation |
Pyrazine derivatives as fgfr inhibitors
|
ES2576692T3
(es)
|
2012-08-13 |
2016-07-08 |
Novartis Tiergesundheit Ag |
Derivados bicíclicos de cicloalquildiamina de heteroarilo como inhibidores de las tirosina quinasas de bazo (SYK)
|
EP2884982B1
(en)
|
2012-08-20 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
RU2656853C2
(ru)
|
2012-08-21 |
2018-06-07 |
Ф. Хоффманн-Ля Рош Аг |
Пирроло[2,3-в]пиразины в качестве ингибиторов syk
|
CN103122000B
(zh)
|
2012-09-03 |
2013-12-25 |
中美冠科生物技术(太仓)有限公司 |
用作抗肿瘤药物的高选择性的c-Met激酶抑制剂
|
DK3181567T3
(da)
|
2012-09-10 |
2019-06-11 |
Principia Biopharma Inc |
Pyrazolopyrimidinforbindelser som kinasehæmmere
|
JP6463680B2
(ja)
|
2012-09-18 |
2019-02-06 |
ジアルコ ファーマ リミテッドZiarco Pharma Ltd |
脾臓チロシンキナーゼi(syk)阻害剤としての2−(2−アミノシクロヘキシル)アミノピリミジン−5−カルボキサミド類
|
WO2014050781A1
(ja)
|
2012-09-25 |
2014-04-03 |
中外製薬株式会社 |
Ret阻害剤
|
EP2900243A4
(en)
|
2012-09-27 |
2016-04-13 |
Portola Pharm Inc |
BICYCLIC OXA LACTAM KINASE HEMMER
|
US9586931B2
(en)
|
2012-09-28 |
2017-03-07 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as Syk inhibitors
|
JP6401169B2
(ja)
|
2012-10-04 |
2018-10-03 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
チロシン受容体キナーゼbtk阻害剤としての置換n−(3−(ピリミジン−4−イル)フェニル)アクリルアミド類似体
|
WO2014055934A2
(en)
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
EP2909174A1
(en)
|
2012-10-19 |
2015-08-26 |
F. Hoffmann-La Roche AG |
Inhibitors of syk
|
CN104640850A
(zh)
|
2012-10-26 |
2015-05-20 |
霍夫曼-拉罗奇有限公司 |
3,4-二取代的1h-吡唑和4,5-二取代的噻唑的syk抑制剂
|
AU2013340345B2
(en)
|
2012-11-02 |
2016-10-27 |
Pfizer Inc. |
Bruton's tyrosine kinase inhibitors
|
CN102977014B
(zh)
|
2012-11-05 |
2015-01-07 |
沈阳药科大学 |
新的喹啉类化合物及其用途
|
US20150284381A1
(en)
|
2012-11-07 |
2015-10-08 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
UA116455C2
(uk)
|
2012-11-13 |
2018-03-26 |
Еррей Біофарма Інк. |
Сполуки n-піролідинілсечовини, n'-піразолілсечовини, тіосечовини, гуанідину та ціаногуанідину як інгібітори кінази trka
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078322A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9546156B2
(en)
|
2012-11-13 |
2017-01-17 |
Array Biopharma Inc. |
N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
BR112015011171A2
(pt)
|
2012-11-15 |
2017-07-11 |
Pharmacyclics Inc |
compostos de pirrolopirimidina como inibidores da quinase
|
CN103848810A
(zh)
|
2012-11-30 |
2014-06-11 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
WO2014086032A1
(en)
|
2012-12-07 |
2014-06-12 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as syk inhibitors
|
US9624210B2
(en)
|
2012-12-12 |
2017-04-18 |
Merck Sharp & Dohme Corp. |
Amino-pyrimidine-containing spleen tyrosine kinase (Syk) inhibitors
|
WO2014100314A1
(en)
|
2012-12-21 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
US9499519B2
(en)
|
2012-12-26 |
2016-11-22 |
Medivation Technologies, Inc. |
Fused pyrimidine compounds and use thereof
|
DK2940014T3
(en)
|
2012-12-28 |
2018-12-10 |
Crystalgenomics Inc |
2,3-DIHYDRO-ISOINDOL-1-ON DERIVATIVE AS BTK KINase INHIBITORS AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
|
JP6321039B2
(ja)
|
2013-01-18 |
2018-05-09 |
グアンヂョウ マキシノヴェル ファーマシューティカル カンパニー リミテッド |
五員かつ六員複素環式化合物並びにその製造方法、医薬品組成物及びその使用
|
US20140206681A1
(en)
|
2013-01-23 |
2014-07-24 |
Ronald M. Kim |
Btk inhibitors
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2014113932A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2014123167A1
(ja)
|
2013-02-08 |
2014-08-14 |
日産化学工業株式会社 |
3環性ピロロピリジン化合物及びjak阻害剤
|
SG11201506514QA
(en)
|
2013-02-19 |
2015-09-29 |
Ono Pharmaceutical Co |
Trk-INHIBITING COMPOUND
|
AR094812A1
(es)
|
2013-02-20 |
2015-08-26 |
Eisai R&D Man Co Ltd |
Derivado de piridina monocíclico como inhibidor del fgfr
|
US9708326B2
(en)
|
2013-02-25 |
2017-07-18 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
JO3377B1
(ar)
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
KR20150132118A
(ko)
|
2013-03-11 |
2015-11-25 |
이그니타, 인코포레이티드 |
퀴나졸린 유도체의 고체 상태 형태 및 braf 저해제로서의 그의 용도
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
WO2014151620A1
(en)
|
2013-03-14 |
2014-09-25 |
Boehringer Ingelheim International Gmbh |
5-thiazolecarboxamide dervatives and their use as btk inhibitors
|
WO2014152114A1
(en)
|
2013-03-15 |
2014-09-25 |
Boehringer Ingelheim International Gmbh |
Heteroaromatic compounds as btk inhibitors
|
AU2014234908B2
(en)
|
2013-03-19 |
2017-08-17 |
Merck Sharp & Dohme Corp. |
N-(2-cyano heterocyclyl)pyrazolo pyridones as Janus kinase inhibitors
|
EP2981264B1
(en)
|
2013-04-02 |
2018-04-25 |
F.Hoffmann-La Roche Ag |
Inhibitors of bruton's tyrosine kinase
|
TWI628176B
(zh)
|
2013-04-04 |
2018-07-01 |
奧利安公司 |
蛋白質激酶抑制劑
|
US10072298B2
(en)
*
|
2013-04-17 |
2018-09-11 |
Life Technologies Corporation |
Gene fusions and gene variants associated with cancer
|
TWI715901B
(zh)
|
2013-04-19 |
2021-01-11 |
美商英塞特控股公司 |
作為fgfr抑制劑之雙環雜環
|
EP2988744A4
(en)
|
2013-04-26 |
2016-11-02 |
Merck Sharp & Dohme |
THIAZOLE SUBSTITUTED AMINOHETEROARYL COMPOUNDS TYLOSINE KINASE SPLENIC INHIBITORS
|
EP2988749B1
(en)
|
2013-04-26 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
CN105143228B
(zh)
|
2013-05-10 |
2017-07-21 |
江苏豪森药业集团有限公司 |
[1,2,4]三唑并[4,3‑a]吡啶类衍生物,其制备方法或其在医药上的应用
|
PL3786162T3
(pl)
|
2013-05-17 |
2024-04-08 |
Incyte Holdings Corporation |
Pochodne bipirazolu jako inhibitory jak
|
CN105408334B
(zh)
|
2013-05-21 |
2017-10-10 |
江苏迈度药物研发有限公司 |
作为激酶抑制剂的取代的吡唑并嘧啶类化合物
|
WO2014193932A1
(en)
|
2013-05-29 |
2014-12-04 |
Cephalon, Inc. |
Pyrrolotriazines as alk inhibitors
|
WO2014204263A1
(en)
|
2013-06-20 |
2014-12-24 |
The Asan Foundation |
Substituted pyridinone compounds as mek inhibitors
|
TW201534597A
(zh)
|
2013-06-20 |
2015-09-16 |
Ab Science |
作為選擇性蛋白質激酶抑制劑之苯并咪唑衍生物
|
ES2708998T3
(es)
|
2013-06-26 |
2019-04-12 |
Abbvie Inc |
Carboxamidas primarias como inhibidores de btk
|
KR102272606B1
(ko)
|
2013-06-28 |
2021-07-05 |
베이진 엘티디 |
Raf 키나아제 및/또는 raf 키나아제 이량체 저해제로서 융합 트리시클릭 우레아 화합물
|
JP6458018B2
(ja)
|
2013-07-02 |
2019-01-23 |
ファーマサイクリックス エルエルシー |
キナーゼ阻害剤としてのプリノン化合物
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
US10407509B2
(en)
|
2013-07-30 |
2019-09-10 |
Blueprint Medicines Corporation |
NTRK2 fusions
|
PT3049417T
(pt)
|
2013-07-31 |
2019-01-24 |
Merck Patent Gmbh |
Piridinas, pirimidinas e pirazinas, como inibidores de btk e utilizações das mesmas
|
AU2014296184B2
(en)
|
2013-07-31 |
2017-04-27 |
Gilead Sciences, Inc. |
Syk inhibitors
|
TW201536291A
(zh)
|
2013-08-02 |
2015-10-01 |
Cephalon Inc |
單獨使用AXL/cMET抑制劑或與其它藥劑組合使用以治療多種癌症之方法
|
DK2947086T3
(en)
|
2013-08-12 |
2018-03-19 |
Taiho Pharmaceutical Co Ltd |
UNKNOWN CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
EP3038652B1
(en)
|
2013-08-28 |
2018-03-21 |
Novartis AG |
Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases
|
US9840517B2
(en)
|
2013-09-18 |
2017-12-12 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Compound inhibiting activities of BTK and/or JAK3 kinases
|
WO2015039334A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
WO2015039333A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
CA2925124A1
(en)
|
2013-09-30 |
2015-04-02 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
MX2016004030A
(es)
|
2013-09-30 |
2016-10-26 |
Beijing Synercare Pharma Tech Co Ltd |
Inhibidores sustituidos de nicotinamida de btk y su preparacion y uso en el tratamiento del cancer, inflamacion y enfermedad autoinmune.
|
DK3059227T3
(da)
|
2013-10-16 |
2019-08-26 |
Fujifilm Corp |
Salt af en nitrogen-holdig heterocyklisk forbindelse eller krystal deraf, farmaceutisk sammensætning og flt3-hæmmer
|
JP6434506B2
(ja)
|
2013-10-21 |
2018-12-05 |
ジェノスコ |
置換ピリミジン化合物およびsyk阻害剤としてのそれらの使用
|
BR112016008632A8
(pt)
|
2013-10-21 |
2020-03-17 |
Merck Patent Gmbh |
compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica
|
JP6403172B2
(ja)
|
2013-10-25 |
2018-10-10 |
シャンハイ ヘンルイ ファーマスーティカル カンパニー リミテッドShanghai Hengrui Pharmaceutical Co., Ltd. |
ピリジンのケトン誘導体、それらの製造方法、およびそれらの医薬適用
|
ES2682493T3
(es)
|
2013-10-25 |
2018-09-20 |
Novartis Ag |
Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de FGFR4
|
WO2015068767A1
(ja)
|
2013-11-08 |
2015-05-14 |
小野薬品工業株式会社 |
ピロロピリミジン誘導体
|
CN104447640B
(zh)
|
2013-12-02 |
2016-07-13 |
北京键凯科技有限公司 |
3-呋喃基-2-氰基-2-丙烯酰胺衍生物及其制备方法、药物组合物和用途
|
EP3077388A1
(en)
|
2013-12-05 |
2016-10-12 |
Pharmacyclics, LLC |
Inhibitors of bruton's tyrosine kinase
|
TWI731317B
(zh)
|
2013-12-10 |
2021-06-21 |
美商健臻公司 |
原肌球蛋白相關之激酶(trk)抑制劑
|
US9783531B2
(en)
|
2013-12-20 |
2017-10-10 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
WO2015095099A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
US9834554B2
(en)
|
2013-12-20 |
2017-12-05 |
Merck Sharp & Dohme Corp. |
BTK inhibitors
|
EP3083559B1
(en)
|
2013-12-20 |
2021-03-10 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
US9670196B2
(en)
|
2013-12-20 |
2017-06-06 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
|
TWI662037B
(zh)
|
2013-12-23 |
2019-06-11 |
美商基利科學股份有限公司 |
脾酪胺酸激酶抑制劑
|
BR112016015057A2
(pt)
|
2013-12-26 |
2017-08-08 |
Ignyta Inc |
Compostos e composições farmacêuticas e respectivos usos
|
JP6486954B2
(ja)
|
2014-01-29 |
2019-03-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Btk阻害剤としてのピラゾール化合物
|
AP2016009297A0
(en)
|
2014-02-03 |
2016-06-30 |
Cadila Healthcare Ltd |
Novel heterocyclic compounds
|
UA120607C2
(uk)
|
2014-02-04 |
2020-01-10 |
Астеллас Фарма Інк. |
Фармацевтична композиція, яка включає діаміно-гетероциклічну карбоксамідну сполуку як активний інгредієнт
|
EP3110815B1
(en)
|
2014-02-27 |
2020-02-19 |
Jiangsu Ascentage Biomed Development Inc. |
Indoloquinolone compounds as anaplastic lymphoma kinase (alk) inhibitors
|
EP3116506B1
(en)
|
2014-03-13 |
2019-04-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
EP3119765B1
(en)
|
2014-03-19 |
2019-07-17 |
Boehringer Ingelheim International GmbH |
Heteroaryl syk inhibitors
|
KR20160127826A
(ko)
|
2014-03-24 |
2016-11-04 |
에이비 사이언스 |
비장 티로신 키나제 억제제로서 치환된 옥사졸 유도체
|
WO2015143654A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
WO2015143653A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
WO2015143652A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
CN106132967B
(zh)
|
2014-03-27 |
2019-05-28 |
詹森药业有限公司 |
作为ros1抑制剂的化合物
|
JP6522646B2
(ja)
|
2014-03-27 |
2019-05-29 |
ヤンセン ファーマシューティカ エヌ.ベー. |
ROS1阻害剤としての置換4,5,6,7−テトラヒドロ−ピラゾロ[1,5−α]ピラジン誘導体および5,6,7,8−テトラヒドロ−4H−ピラゾロ[1,5−α][1,4]ジアゼピン誘導体
|
CN106458914B
(zh)
|
2014-03-28 |
2020-01-14 |
常州捷凯医药科技有限公司 |
作为axl抑制剂的杂环化合物
|
CN105017256A
(zh)
|
2014-04-29 |
2015-11-04 |
浙江导明医药科技有限公司 |
多氟化合物作为布鲁顿酪氨酸激酶抑制剂
|
CN105085474B
(zh)
|
2014-05-07 |
2018-05-18 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
NZ725001A
(en)
|
2014-05-14 |
2021-08-27 |
Nissan Chemical Ind Ltd |
Tricyclic compound and jak inhibitor
|
RS59286B1
(sr)
|
2014-05-15 |
2019-10-31 |
Array Biopharma Inc |
1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)urea kao inhibitor trka kinaze
|
CN105294654B
(zh)
|
2014-05-30 |
2018-01-09 |
北京浦润奥生物科技有限责任公司 |
Alk激酶抑制剂及其制备方法和应用
|
CN106459007B
(zh)
|
2014-06-17 |
2020-02-28 |
韩国化学研究院 |
嘧啶-2,4-二胺衍生物及包含其作为有效成分的抗癌用药学组合物
|
US9394305B2
(en)
|
2014-06-23 |
2016-07-19 |
Dr. Reddy's Laboratories Ltd. |
Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors
|
TWI723572B
(zh)
|
2014-07-07 |
2021-04-01 |
日商第一三共股份有限公司 |
具有四氫吡喃基甲基之吡啶酮衍生物及其用途
|
TW201617074A
(zh)
|
2014-07-14 |
2016-05-16 |
吉李德科學股份有限公司 |
Syk(脾酪胺酸激酶)抑制劑
|
AU2015296215A1
(en)
|
2014-08-01 |
2017-03-23 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
JP6618120B2
(ja)
|
2014-08-06 |
2019-12-11 |
塩野義製薬株式会社 |
TrkA阻害活性を有する複素環および炭素環誘導体
|
NO2721710T3
(US07122603-20061017-C00250.png)
|
2014-08-21 |
2018-03-31 |
|
|
KR101710127B1
(ko)
|
2014-08-29 |
2017-02-27 |
한화제약주식회사 |
야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민
|
US20170281641A1
(en)
|
2014-09-03 |
2017-10-05 |
Genzyme Corporation |
CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS
|
CN105524068B
(zh)
|
2014-09-30 |
2017-11-24 |
上海海雁医药科技有限公司 |
氮杂双环衍生物、其制法与医药上的用途
|
US20180185341A1
(en)
|
2014-10-03 |
2018-07-05 |
Novartis Ag |
Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
|
SG11201701573QA
(en)
|
2014-10-06 |
2017-03-30 |
Merck Patent Gmbh |
Heteroaryl compounds as btk inhibitors and uses thereof
|
CN111170999B
(zh)
|
2014-10-11 |
2023-06-30 |
上海翰森生物医药科技有限公司 |
Egfr抑制剂及其制备和应用
|
AU2015335783B2
(en)
|
2014-10-24 |
2019-10-03 |
Bristol-Myers Squibb Company |
Tricyclic atropisomer compounds
|
CA2965559A1
(en)
|
2014-10-30 |
2016-05-06 |
Sandoz Ag |
Active acrylamides
|
CN111170998B
(zh)
|
2014-11-05 |
2023-04-11 |
益方生物科技(上海)股份有限公司 |
嘧啶或吡啶类化合物、其制备方法和医药用途
|
WO2016079763A1
(en)
|
2014-11-20 |
2016-05-26 |
Council Of Scientific & Industrial Research |
Novel benzimidazole based egfr inhibitors
|
CN105601573B
(zh)
|
2014-11-24 |
2021-07-02 |
中国科学院上海药物研究所 |
2-氨基嘧啶类化合物及其药物组合物和应用
|
MX2017007656A
(es)
|
2014-12-11 |
2017-10-11 |
Bayer Pharma AG |
Uso de los inhibidores de pan fgfr y metodo para identificacion de pacientes con cancer elegibles para el tratamiento con un inhibidor de pan fgfr.
|
ES2746839T3
(es)
|
2014-12-18 |
2020-03-09 |
Pfizer |
Derivados de pirimidina y triazina y su uso como inhibidores de AXL
|
WO2016104617A1
(ja)
|
2014-12-25 |
2016-06-30 |
小野薬品工業株式会社 |
キノリン誘導体
|
WO2016106629A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106626A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
WO2016106624A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Tertiary alcohol imidazopyrazine btk inhibitors
|
WO2016106627A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106652A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Biarylether imidazopyrazine btk inhibitors
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
CN104530063B
(zh)
|
2015-01-13 |
2017-01-18 |
北京赛特明强医药科技有限公司 |
喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用
|
CN105837576B
(zh)
|
2015-01-14 |
2019-03-26 |
湖北生物医药产业技术研究院有限公司 |
Btk抑制剂
|
CA2979425C
(en)
|
2015-01-20 |
2020-04-14 |
Wuxi Fortune Pharmaceutical Co., Ltd |
Jak inhibitor
|
WO2016116900A1
(en)
|
2015-01-23 |
2016-07-28 |
Gvk Biosciences Private Limited |
Inhibitors of trka kinase
|
US20180050993A1
(en)
|
2015-02-03 |
2018-02-22 |
Trillium Therapeutics Inc. |
Novel fluorinated derivatives as egfr inhibitors useful for treating cancers
|
EP3253750B1
(en)
|
2015-02-03 |
2019-04-10 |
Council of Scientific and Industrial Research |
Novel flavone based egfr inhibitors and process for preparation thereof
|
CN113004278B
(zh)
|
2015-02-20 |
2023-07-21 |
因赛特控股公司 |
作为fgfr抑制剂的双环杂环
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
WO2016161570A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Azacarbazole btk inhibitors
|
WO2016161572A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
KR102499359B1
(ko)
|
2015-04-14 |
2023-02-10 |
주식회사 큐리언트 |
Tam rtk 억제제로서 퀴놀린 유도체들
|
UA119701C2
(uk)
|
2015-04-29 |
2019-07-25 |
Вуксі Фортуне Фармасьютікал Ко., Лтд |
Піримідинові сполуки як jak-інгібітори
|
AU2016267141B2
(en)
|
2015-05-28 |
2020-04-16 |
Theravance Biopharma R&D Ip, Llc |
Naphthyridine compounds as jak kinase inhibitors
|
AU2016271904B2
(en)
|
2015-05-29 |
2018-05-10 |
Wuxi Fortune Pharmaceutical Co.,Ltd |
Janus kinase inhibitor
|
SG10201911523YA
(en)
|
2015-06-02 |
2020-02-27 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
TWI810582B
(zh)
|
2015-06-03 |
2023-08-01 |
美商普林斯匹亞生物製藥公司 |
酪胺酸激酶抑制劑
|
WO2016192074A1
(en)
|
2015-06-04 |
2016-12-08 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
TW201718572A
(zh)
|
2015-06-24 |
2017-06-01 |
普林斯匹亞生物製藥公司 |
酪胺酸激酶抑制劑
|
EP3321271B1
(en)
|
2015-07-07 |
2024-05-29 |
Japan Tobacco Inc. |
Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
|
US10640495B2
(en)
|
2015-07-07 |
2020-05-05 |
Shionogi & Co., Ltd. |
Heterocycle derivatives having TrkA inhibitory activity
|
MX2017016619A
(es)
|
2015-07-09 |
2018-05-15 |
Merck Patent Gmbh |
Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
|
AU2016292450B2
(en)
|
2015-07-16 |
2021-03-25 |
Centaurus Biopharma Co., Ltd. |
Aniline pyrimidine derivatives and uses thereof
|
LT3322706T
(lt)
|
2015-07-16 |
2021-03-10 |
Array Biopharma, Inc. |
Pakeistieji pirazolo[1,5-a]piridino junginiai, kaip ret kinazės inhibitoriai
|
WO2017015363A1
(en)
|
2015-07-20 |
2017-01-26 |
Dana-Farber Cancer Institute, Inc. |
Novel pyrimidines as egfr inhibitors and methods of treating disorders
|
CN108138177B9
(zh)
*
|
2015-07-23 |
2021-08-13 |
法国居里学院 |
Dbait分子与PARP抑制剂的组合用于治疗癌症的用途
|
WO2017016463A1
(zh)
|
2015-07-24 |
2017-02-02 |
上海海雁医药科技有限公司 |
Egfr抑制剂及其药学上可接受的盐和多晶型物及其应用
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
CN106467541B
(zh)
|
2015-08-18 |
2019-04-05 |
暨南大学 |
取代喹诺酮类衍生物或其药学上可接受的盐或立体异构体及其药用组合物和应用
|
EP3339305B1
(en)
|
2015-08-20 |
2022-05-04 |
Zhejiang Hisun Pharmaceutical Co., Ltd |
Indole derivative, preparation method thereof, and use thereof in pharmaceutical drug
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
AU2016322063A1
(en)
|
2015-09-16 |
2018-04-12 |
Loxo Oncology, Inc. |
Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer
|
EP3144307A1
(en)
|
2015-09-18 |
2017-03-22 |
AB Science |
Novel oxazole derivatives that inhibit syk
|
CN106554347B
(zh)
|
2015-09-25 |
2020-10-30 |
浙江博生医药有限公司 |
Egfr激酶抑制剂及其制备方法和应用
|
US10526309B2
(en)
|
2015-10-02 |
2020-01-07 |
The University Of North Carolina At Chapel Hill |
Pan-TAM inhibitors and Mer/Axl dual inhibitors
|
CA3008653A1
(en)
|
2015-10-14 |
2017-04-20 |
Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|
AU2016341445B2
(en)
|
2015-10-23 |
2020-08-27 |
Array Biopharma, Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
|
CA3001542C
(en)
|
2015-11-03 |
2021-02-16 |
Theravance Biopharma R&D Ip, Llc |
Jak kinase inhibitor compounds for treatment of respiratory disease
|
CN106699743B
(zh)
|
2015-11-05 |
2020-06-12 |
湖北生物医药产业技术研究院有限公司 |
嘧啶类衍生物及其用途
|
JP6890602B2
(ja)
|
2015-11-06 |
2021-06-18 |
アセルタ ファーマ ビー.ブイ. |
ブルトン型チロシンキナーゼのイミダゾピラジン阻害剤
|
US10370379B2
(en)
|
2015-11-19 |
2019-08-06 |
Blueprint Medicines Corporation |
Compounds and compositions useful for treating disorders related to NTRK
|
ME03757B
(me)
|
2015-11-24 |
2021-04-20 |
Theravance Biopharma R&D Ip Llc |
Prolekovi jaki inhibitornih jedinjenja za lečenje gastorintestinalne inflamatorne bolesti
|
EP3360878B9
(en)
|
2015-12-11 |
2021-05-05 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Azetidine derivative, preparation method therefor, and use thereof
|
RS62525B1
(sr)
|
2015-12-16 |
2021-11-30 |
Boehringer Ingelheim Int |
Bipirazolil derivati korisni za lečenje autoimunih oboljenja
|
CN106928231B
(zh)
|
2015-12-31 |
2021-06-01 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的egfr野生型和突变型的激酶抑制剂
|
WO2017117680A1
(en)
|
2016-01-06 |
2017-07-13 |
Trillium Therapeutics Inc. |
Novel fluorinated quinazoline derivatives as egfr inhibitors
|
CA3010890C
(en)
|
2016-01-11 |
2023-09-26 |
Merck Patent Gmbh |
Quinolin-2-one derivatives
|
EP3402789B1
(en)
|
2016-01-13 |
2020-03-18 |
Boehringer Ingelheim International Gmbh |
Isoquinolones as btk inhibitors
|
JP6950897B2
(ja)
|
2016-01-21 |
2021-10-13 |
ジーボ・バイオポーラー・チャンシェン・ファーマシューティカル・カンパニー・リミテッドZibo Biopolar Changsheng Pharmaceutical Co. Ltd. |
ブルトン型チロシンキナーゼ阻害剤
|
EP3409673B1
(en)
|
2016-01-26 |
2021-06-16 |
Hangzhou Bangshun Pharmaceutical Co., Ltd. |
Pyrrolopyrimidine five-membered azacyclic derivative and application thereof
|
CN107021963A
(zh)
|
2016-01-29 |
2017-08-08 |
北京诺诚健华医药科技有限公司 |
吡唑稠环类衍生物、其制备方法及其在治疗癌症、炎症和免疫性疾病上的应用
|
US10533006B2
(en)
|
2016-02-04 |
2020-01-14 |
Shionogi & Co., Ltd. |
Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity
|
RU2744432C2
(ru)
|
2016-02-19 |
2021-03-09 |
Цзянсу Хэнжуй Медицин Ко., Лтд. |
Фармацевтическая композиция, включающая ингибитор янус-киназы или его фармацевтически приемлемую соль
|
IL261107B2
(en)
|
2016-02-23 |
2023-11-01 |
Taiho Pharmaceutical Co Ltd |
A novel compressed pyrimidine compound or a salt thereof
|
EP3423068A1
(en)
*
|
2016-03-01 |
2019-01-09 |
Onxeo |
Treatment of cancer by systemic administration of dbait molecules
|
CN107151249B
(zh)
|
2016-03-04 |
2020-08-14 |
华东理工大学 |
作为flt3抑制剂的蝶啶酮衍生物及应用
|
AR107912A1
(es)
|
2016-03-17 |
2018-06-28 |
Blueprint Medicines Corp |
Inhibidores de ret
|
CN107286077B
(zh)
|
2016-04-01 |
2021-04-02 |
合肥中科普瑞昇生物医药科技有限公司 |
一种选择性的c-kit激酶抑制剂
|
JP2019514899A
(ja)
|
2016-04-29 |
2019-06-06 |
エックス−ケム,インコーポレーテッド |
共有結合型btk阻害剤及びその使用
|
CN109311858B
(zh)
|
2016-05-26 |
2021-12-03 |
里科瑞尔姆Ip控股有限责任公司 |
Egfr抑制剂化合物
|
CN107759600A
(zh)
|
2016-06-16 |
2018-03-06 |
正大天晴药业集团股份有限公司 |
作为jak抑制剂的吡咯并嘧啶化合物的结晶
|
CN107540666B
(zh)
|
2016-06-27 |
2023-03-24 |
杭州雷索药业有限公司 |
苯并呋喃吡唑胺类蛋白激酶抑制剂
|
WO2018002958A1
(en)
|
2016-06-30 |
2018-01-04 |
Sun Pharma Advanced Research Company Limited |
Novel hydrazide containing compounds as btk inhibitors
|
AU2017287553B2
(en)
|
2016-06-30 |
2020-02-06 |
Hangzhou BANGSHUN Pharmaceutical Co., Ltd |
Imidazopyrazinamine phenyl derivative and use thereof
|
KR102327917B1
(ko)
|
2016-07-07 |
2021-11-17 |
주식회사 대웅제약 |
신규한 4-아미노피라졸로[3,4-d]피리미디닐아자바이사이클로 유도체 및 이를 포함하는 약학 조성물
|
CN107619388A
(zh)
|
2016-07-13 |
2018-01-23 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
US10227329B2
(en)
|
2016-07-22 |
2019-03-12 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
US10035789B2
(en)
|
2016-07-27 |
2018-07-31 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
CN107698593A
(zh)
|
2016-08-09 |
2018-02-16 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
WO2018035080A1
(en)
|
2016-08-16 |
2018-02-22 |
Merck Patent Gmbh |
2-oxo-imidazopyridines as reversible btk inhibitors and uses thereof
|
JP7094566B2
(ja)
|
2016-08-29 |
2022-07-04 |
ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン |
Alk阻害剤としてのアミノピリミジン類
|
EP3512519A1
(en)
|
2016-09-14 |
2019-07-24 |
Gilead Sciences, Inc. |
Syk inhibitors
|
TW201822764A
(zh)
|
2016-09-14 |
2018-07-01 |
美商基利科學股份有限公司 |
Syk抑制劑
|
CN107840842A
(zh)
|
2016-09-19 |
2018-03-27 |
北京天诚医药科技有限公司 |
炔代杂环化合物、其制备方法及其在医药学上的应用
|
CN107840846B
(zh)
|
2016-09-19 |
2020-11-24 |
郑州泰基鸿诺医药股份有限公司 |
一种含嘧啶环的化合物、egfr抑制剂及其应用
|
JP2018052878A
(ja)
|
2016-09-29 |
2018-04-05 |
第一三共株式会社 |
ピリジン化合物
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|
WO2018079759A1
(ja)
|
2016-10-31 |
2018-05-03 |
塩野義製薬株式会社 |
TrkA阻害活性を有する縮合複素環および縮合炭素環誘導体
|
KR20180051220A
(ko)
|
2016-11-08 |
2018-05-16 |
주식회사 대웅제약 |
신규한 피롤로피리미딘 유도체 및 이를 포함하는 약학적 조성물
|
JP6782855B2
(ja)
|
2016-11-15 |
2020-11-11 |
杭州和正医薬有限公司 |
選択性ブルトン型チロシンキナーゼ阻害剤及びその使用
|
CN110191886A
(zh)
|
2016-11-18 |
2019-08-30 |
密执安大学评议会 |
5,6-二氢-11h-吲哚并[2,3-b]喹啉-11-酮作为alk抑制剂
|
CN108101905A
(zh)
|
2016-11-24 |
2018-06-01 |
中国科学院上海药物研究所 |
嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途
|
WO2018108083A1
(zh)
|
2016-12-12 |
2018-06-21 |
杭州英创医药科技有限公司 |
作为Syk抑制剂和/或Syk-HDAC双重抑制剂的杂环化合物
|
WO2018108064A1
(zh)
|
2016-12-13 |
2018-06-21 |
南京明德新药研发股份有限公司 |
作为第四代egfr激酶抑制剂的螺环芳基磷氧化合物
|
EP3555090A1
(en)
|
2016-12-15 |
2019-10-23 |
ARIAD Pharmaceuticals, Inc. |
Aminothiazole compounds as c-kit inhibitors
|
MX2019007080A
(es)
|
2016-12-15 |
2019-10-15 |
Ariad Pharma Inc |
Compuestos de benzimidazol como inhibidores de c-kit.
|
CN108250200A
(zh)
|
2016-12-28 |
2018-07-06 |
中国科学院上海药物研究所 |
一种具有Axl抑制活性的化合物及其制备和应用
|
CN110139865B
(zh)
|
2016-12-29 |
2022-02-18 |
石药集团中奇制药技术(石家庄)有限公司 |
Fgfr抑制剂
|
US11040984B2
(en)
|
2016-12-30 |
2021-06-22 |
Medshine Discovery Inc. |
Quinazoline compound for EGFR inhibition
|
CN108276410B
(zh)
|
2017-01-06 |
2021-12-10 |
首药控股(北京)股份有限公司 |
一种间变性淋巴瘤激酶抑制剂及其制备方法和用途
|
CN115737636A
(zh)
|
2017-01-10 |
2023-03-07 |
王巍 |
拉索昔芬调节膜结合雌激素信号的应用及治疗癌症的方法
|
CA3049136C
(en)
|
2017-01-18 |
2022-06-14 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors
|
WO2018136663A1
(en)
|
2017-01-18 |
2018-07-26 |
Array Biopharma, Inc. |
Ret inhibitors
|
CN106831787B
(zh)
|
2017-01-20 |
2018-10-23 |
成都倍特药业有限公司 |
用作布鲁顿酪氨酸激酶抑制剂的化合物及其制备方法和应用
|
WO2018145525A1
(zh)
|
2017-02-08 |
2018-08-16 |
中国医药研究开发中心有限公司 |
吡咯并芳杂环类化合物及其制备方法和医药用途
|
US10464923B2
(en)
|
2017-02-27 |
2019-11-05 |
Merck Patent Gmbh |
Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone
|
WO2018153293A1
(zh)
|
2017-02-27 |
2018-08-30 |
北京赛特明强医药科技有限公司 |
二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用
|
CN110382499B
(zh)
|
2017-02-27 |
2023-01-03 |
贝达药业股份有限公司 |
Fgfr抑制剂及其应用
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
KR102627756B1
(ko)
|
2017-03-22 |
2024-01-23 |
쑤저우 바이지부공 파마수티컬 테크널러지 컴퍼니 리미티드 |
브루톤 타이로신 키나제 억제제
|
WO2018187355A1
(en)
|
2017-04-03 |
2018-10-11 |
Health Research Inc. |
Met kinase inhibitors and uses therefor
|
CN108721298A
(zh)
|
2017-04-19 |
2018-11-02 |
华东理工大学 |
作为布鲁顿酪氨酸激酶抑制剂的嘧啶并杂环化合物及其应用
|
CN108727382B
(zh)
|
2017-04-19 |
2022-07-19 |
华东理工大学 |
作为btk抑制剂的杂环化合物及其应用
|
CN107043366B
(zh)
|
2017-04-25 |
2020-05-26 |
中国药科大学 |
4-氨基嘧啶类化合物、其制备方法及医药用途
|
MX2019012827A
(es)
|
2017-04-27 |
2020-02-12 |
Mochida Pharm Co Ltd |
Derivados de tetrahidronaftilo urea novedosos.
|
AR111495A1
(es)
|
2017-05-01 |
2019-07-17 |
Theravance Biopharma R&D Ip Llc |
Compuestos de imidazo-piperidina fusionada como inhibidores de jak
|
WO2018208132A1
(en)
|
2017-05-12 |
2018-11-15 |
Korea Research Institute Of Chemical Technology |
Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient
|
US20180334465A1
(en)
|
2017-05-22 |
2018-11-22 |
Genentech, Inc. |
Therapeutic compounds and compositions, and methods of use thereof
|
CR20190520A
(es)
|
2017-05-22 |
2020-01-21 |
Hoffmann La Roche |
Composiciones y compuestos terapéuticos y métodos para utilizarlos
|
CN107176954B
(zh)
|
2017-06-02 |
2019-01-11 |
无锡双良生物科技有限公司 |
一种egfr抑制剂的药用盐及其晶型、制备方法和应用
|
CN110678461B
(zh)
|
2017-06-14 |
2021-08-10 |
正大天晴药业集团股份有限公司 |
Syk抑制剂及其使用方法
|
CN109111446B
(zh)
|
2017-06-22 |
2021-11-30 |
上海度德医药科技有限公司 |
一种具有药物活性的杂芳基化合物
|
MX2020000135A
(es)
|
2017-06-27 |
2020-07-22 |
Janssen Pharmaceutica Nv |
Nuevos compuestos de quinolinona.
|
CN111093645A
(zh)
|
2017-07-05 |
2020-05-01 |
Cs制药技术有限公司 |
Egfr酪氨酸激酶的临床上重要的突变体的选择性抑制剂
|
CN110997677A
(zh)
|
2017-08-12 |
2020-04-10 |
百济神州有限公司 |
具有改进的双重选择性的Btk抑制剂
|
WO2019034075A1
(zh)
|
2017-08-15 |
2019-02-21 |
南京明德新药研发股份有限公司 |
Fgfr和egfr抑制剂
|
WO2019034076A1
(zh)
|
2017-08-15 |
2019-02-21 |
南京明德新药研发股份有限公司 |
Fgfr抑制剂及其医药用途
|
WO2019034153A1
(zh)
|
2017-08-18 |
2019-02-21 |
北京韩美药品有限公司 |
一种化合物,其药物组合物及其用途及应用
|
CN109400610A
(zh)
|
2017-08-18 |
2019-03-01 |
浙江海正药业股份有限公司 |
吡咯并三嗪类衍生物、其制备方法及其在医药上的用途
|
EP3668867B1
(en)
|
2017-08-18 |
2023-10-04 |
Universität Regensburg |
Synthesis, pharmacology and use of new and selective fms-like tyrosine kinase 3 (flt3) flt3 inhibitors
|